CHK2-independent induction of telomere dysfunction checkpoints in stem and progenitor cells

Area of Science:

• Cellular senescence
• Telomere biology
• DNA damage response

Background:

• Telomere shortening triggers senescence, limiting cell proliferation.
• This process is typically mediated by ataxia telangiectasia mutated (ATM)-dependent p53 activation.
• The role of CHK2 in this pathway, particularly in vivo, requires further elucidation.

Purpose of the Study:

• To investigate the role of CHK2 in mediating senescence induction in response to telomere shortening.
• To determine if CHK2 deletion impacts stem cell function, organ maintenance, or lifespan in telomere-dysfunctional mice.
• To assess the effect of CHK2 deletion on p53/p21 induction, apoptosis, and cell-cycle arrest in progenitor cells.

Main Methods:

• Fibroblast cultures from wild-type and CHK2-deficient mice and humans.
• Telomere dysfunction induction models.
• Assessment of senescence markers (e.g., p53, p21).
• Evaluation of stem cell function, organ integrity, and lifespan in mouse models.
• Analysis of apoptosis and cell-cycle arrest in progenitor cells.

Main Results:

• CHK2 deletion significantly impaired the induction of senescence in both mouse and human fibroblasts.
• However, CHK2 deletion did not rescue stem cell function, organ maintenance, or lifespan in telomere-dysfunctional mice.
• Furthermore, CHK2 deletion did not prevent the induction of p53/p21, apoptosis, or cell-cycle arrest in telomere-dysfunctional progenitor cells.

Conclusions:

• CHK2 plays a critical role in mediating fibroblast senescence induced by telomere shortening.
• CHK2 is dispensable for the activation of telomere dysfunction checkpoints in vivo at the stem and progenitor cell level.
• These findings differentiate the role of CHK2 in somatic cell senescence versus stem/progenitor cell responses to telomere damage.